New FDA Guidance Allows Companies to Continue Marketing Infant Formula Under an Enforcement Discretion Letter Beyond November 14, 2022

 After the publication of its May 2022 Enforcement Discretion Guidance (discussed here), FDA issued letters of enforcement discretion to various companies for marketing specific infant formula products in the United States without having submitted a mandatory new infant formula notice and perhaps not meeting all regulatory and statutory requirements for infant formula.  FDA’s policy is... Continue Reading